{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:35Z","timestamp":1787020175215,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Institute of Medical Information Chinese Academy Medical Sciences Youth Talent Development Fund","award":["2024YT02"],"award-info":[{"award-number":["2024YT02"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFF0711900"],"award-info":[{"award-number":["2022YFF0711900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2024-ZHCH630-01"],"award-info":[{"award-number":["2024-ZHCH630-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11791-9","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T20:35:09Z","timestamp":1763411709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of human papillomavirus infection and its associations with metabolic risk factors in China: a nationwide population-based study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yunli","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heling","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sailimai","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"6","key":"11791_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.2023.13174","volume":"330","author":"RB Perkins","year":"2023","unstructured":"Perkins RB, Wentzensen N, Guido RS, Schiffman M. Cervical cancer screening: a review. JAMA. 2023;330(6):547\u201358.","journal-title":"JAMA"},{"issue":"2","key":"11791_CR2","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh D, Vignat J, Lorenzoni V, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical cancer elimination initiative. Lancet Glob Health. 2023;11(2):e197\u2013206.","journal-title":"Lancet Glob Health"},{"key":"11791_CR3","first-page":"1184","volume":"103","author":"[Chinese expert consensus on the use","year":"2023","unstructured":"[Chinese expert consensus on the use. Of human papillomavirus nucleic acid testing for cervical cancer screening (2022)]. Zhonghua Yi Xue Za Zhi. 2023;103:1184\u201395.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"11791_CR4","unstructured":"American Cancer Society. HPV and, Testing HPV. February. Available online: https:\/\/www.cancer.org\/cancer\/cancer-causes\/infectious-agents\/hpv\/hpv-and-hpv-testing.html. Accessed at 23 Feb 2024."},{"issue":"7\u20138","key":"11791_CR5","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1080\/21645515.2019.1600985","volume":"15","author":"MR Timbang","year":"2019","unstructured":"Timbang MR, Sim MW, Bewley AF, Farwell DG, Mantravadi A, Moore MG. HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection. Hum Vaccin Immunother. 2019;15(7\u20138):1920\u20138.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"11791_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jiph.2018.06.005","volume":"12","author":"J Krzowska-Firych","year":"2019","unstructured":"Krzowska-Firych J, Lucas G, Lucas C, Lucas N, Pietrzyk \u0141. An overview of human papillomavirus (HPV) as an etiological factor of the anal cancer. J Infect Public Health. 2019;12(1):1\u20136.","journal-title":"J Infect Public Health"},{"issue":"3","key":"11791_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ygyno.2022.06.014","volume":"166","author":"CL Rasmussen","year":"2022","unstructured":"Rasmussen CL, Thomsen LT, Baandrup L, et al. Changes in HPV prevalence in Danish women with vulvar cancer during 28 years - A nationwide study of >\u20091300 cancer cases. Gynecol Oncol. 2022;166(3):589\u201395.","journal-title":"Gynecol Oncol"},{"issue":"11","key":"11791_CR8","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356.","journal-title":"Lancet Oncol"},{"issue":"4","key":"11791_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/jmv.21429","volume":"81","author":"BD Bello","year":"2009","unstructured":"Bello BD, Spinillo A, Alberizzi P, et al. Cervical infections by multiple human papillomavirus (HPV) genotypes: prevalence and impact on the risk of precancerous epithelial lesions. J Med Virol. 2009;81(4):703\u201312.","journal-title":"J Med Virol"},{"issue":"11","key":"11791_CR10","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1086\/428850","volume":"191","author":"R Herrero","year":"2005","unstructured":"Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis. 2005;191(11):1796\u2013807.","journal-title":"J Infect Dis"},{"key":"11791_CR11","unstructured":"ICO\/IARC HPV Information Centre. Human Papillomavirus and Related Diseases Report. China. Available online: https:\/\/hpvcentre.net\/statistics\/reports\/CHN.pdf. Accessed at 9 April 2024."},{"issue":"11","key":"11791_CR12","first-page":"300","volume":"64","author":"E Petrosky","year":"2015","unstructured":"Petrosky E, Bocchini JA Jr., Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"11791_CR13","unstructured":"China National Medical Products Administration. HPV Vaccine and Prevention of Cervical Cancer [in Chinese]. (2019). Available online at: https:\/\/www.nmpa.gov.cn\/xxgk\/kpzhsh\/kpzhshyp\/20190722080001877.html. Accessed at 9 April 2024."},{"issue":"4","key":"11791_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jinf.2021.02.017","volume":"82","author":"HL Bao","year":"2021","unstructured":"Bao HL, Jin C, Wang S, et al. Prevalence of cervicovaginal human papillomavirus infection and genotypes in the pre-vaccine era in China: a nationwide population-based study. J Infect. 2021;82(4):75\u201383.","journal-title":"J Infect"},{"issue":"2","key":"11791_CR15","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.08.020405","volume":"8","author":"K Ogunsina","year":"2018","unstructured":"Ogunsina K, Dibaba DT, Akinyemiju T. Association between life-course socio-economic status and prevalence of cardio-metabolic risk ractors in five middle-income countries. J Glob Health. 2018;8(2):020405.","journal-title":"J Glob Health"},{"issue":"7","key":"11791_CR16","first-page":"904","volume":"39","author":"ZH Wang","year":"2018","unstructured":"Wang ZH, Zhang B, Wang HJ, Wang LS, Ding GG. [Prevalence of cardio metabolic risk factors and related socio-demographic factors in adults aged 18\u201359 years in 15 provinces of China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39(7):904\u20138.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"11791_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.972963","volume":"13","author":"C Yue","year":"2022","unstructured":"Yue C, Zhang C, Ying C, Jiang H. Diabetes associated with HPV infection in women aged over 50 years: a cross-sectional study from China\u2019s largest academic woman\u2019s hospital. Front Endocrinol (Lausanne). 2022;13:972963.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"11791_CR18","volume":"12","author":"YC Zhou","year":"2025","unstructured":"Zhou YC, Liu JM, Zhao ZP, Zhou MG, Ng M. The national and provincial prevalence and non-fatal burdens of diabetes in China from 2005 to 2023 with projections of prevalence to 2050. Mil Med Res. 2025;12(1):28.","journal-title":"Mil Med Res"},{"issue":"06","key":"11791_CR19","first-page":"521","volume":"40","author":"NCC Diseases","year":"2025","unstructured":"Diseases NCC, TWCotRoC H. China Di. National center for cardiovascular diseases. Chin Circulation J. 2025;40(06):521\u201359.","journal-title":"Chin Circulation J"},{"issue":"6","key":"11791_CR20","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","volume":"121","author":"P Joseph","year":"2017","unstructured":"Joseph P, Leong D, McKee M, et al. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res. 2017;121(6):677\u201394.","journal-title":"Circ Res"},{"issue":"10","key":"11791_CR21","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.cmet.2021.08.005","volume":"33","author":"W Wang","year":"2021","unstructured":"Wang W, Hu M, Liu H, et al. Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease. Cell Metab. 2021;33(10):1943-56.e2.","journal-title":"Cell Metab"},{"issue":"25","key":"11791_CR22","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"11791_CR23","doi-asserted-by":"publisher","first-page":"155744","DOI":"10.1016\/j.metabol.2023.155744","volume":"152","author":"DJH Tan","year":"2024","unstructured":"Tan DJH, Ng CH, Muthiah M, et al. Rising global burden of cancer attributable to high BMI from 2010 to 2019. Metabolism. 2024;152:155744.","journal-title":"Metabolism"},{"issue":"3","key":"11791_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.cyto.2010.11.014","volume":"53","author":"R Baker","year":"2011","unstructured":"Baker R, Dauner JG, Rodriguez AC, et al. Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection. Cytokine. 2011;53(3):282\u20135.","journal-title":"Cytokine"},{"issue":"2","key":"11791_CR25","first-page":"107","volume":"1755","author":"JI B\u00e1rdos","year":"2005","unstructured":"B\u00e1rdos JI, Ashcroft M. Negative and positive regulation of HIF-1: a complex network. Biochim Biophys Acta. 2005;1755(2):107\u201320.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"11791_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ygyno.2021.02.009","volume":"161","author":"J Lee","year":"2021","unstructured":"Lee J, Kim HS, Kim K, Bae DS, Kim BG, Choi CH. Metabolic syndrome and persistent cervical human papillomavirus infection. Gynecol Oncol. 2021;161(2):559\u201364.","journal-title":"Gynecol Oncol"},{"key":"11791_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2024.101438","volume":"54","author":"R Kajabwangu","year":"2024","unstructured":"Kajabwangu R, Izudi J, Bazira J, et al. Effect of metabolic syndrome and its components on the risk and prognosis of cervical cancer: a literature review. Gynecol Oncol Rep. 2024;54:101438.","journal-title":"Gynecol Oncol Rep"},{"key":"11791_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.annepidem.2020.07.011","volume":"49","author":"A Urbute","year":"2020","unstructured":"Urbute A, Thomsen LT, Belmonte F, Kesmodel US, Frederiksen K, Kjaer SK. The role of body mass index in incidence and persistence of cervical human papillomavirus infection. Ann Epidemiol. 2020;49:36\u201341.","journal-title":"Ann Epidemiol"},{"issue":"7","key":"11791_CR29","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/infdis\/jit297","volume":"208","author":"SH Liu","year":"2013","unstructured":"Liu SH, Rositch AF, Viscidi RP, Silver MI, Burke AE, Gravitt PE. Obesity and human papillomavirus infection in perimenopausal women. J Infect Dis. 2013;208(7):1071\u201380.","journal-title":"J Infect Dis"},{"issue":"1","key":"11791_CR30","first-page":"70","volume":"34","author":"US Jung","year":"2013","unstructured":"Jung US, Choi JS, Ko JH, Lee JH, Park SY, Park SH. Decreased prevalence of high-risk human papillomavirus infection is associated with obesity. Eur J Gynaecol Oncol. 2013;34(1):70\u20134.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"9","key":"11791_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002905","volume":"95","author":"X Huang","year":"2016","unstructured":"Huang X, Zhao Q, Yang P, et al. Metabolic syndrome and risk of cervical human papillomavirus incident and persistent infection. Medicine. 2016;95(9):e2905.","journal-title":"Medicine"},{"issue":"9","key":"11791_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"key":"11791_CR33","unstructured":"National Bureau of Statistics, the People\u2019s Republic of China. Statistical Yearbook of China (in Chinese), 2019. Available at: http:\/\/www.stats.gov.cn\/. Accessed at 14 Jan 2024."},{"issue":"19","key":"11791_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.46234\/ccdcw2024.080","volume":"6","author":"C Junlei","year":"2024","unstructured":"Junlei C, Zhaonan Z, Weiyi P, et al. Preplanned studies: estimated human papillomavirus vaccine coverage among females 9\u201345 years of Age \u2014 China, 2017\u20132022. China CDC Wkly. 2024;6(19):413\u20137.","journal-title":"China CDC Wkly"},{"key":"11791_CR35","unstructured":"World Health Organization. Human Papillomavirus and Cancer. 2023. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/human-papilloma-virus-and-cancer. Accessed at 9 Apr 2024."},{"issue":"6","key":"11791_CR36","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1002\/jmv.27478","volume":"94","author":"Z Dai","year":"2022","unstructured":"Dai Z, Si M, Su X, et al. Willingness to human papillomavirus (HPV) vaccination and influencing factors among male and female university students in China. J Med Virol. 2022;94(6):2776\u201386.","journal-title":"J Med Virol"},{"issue":"1","key":"11791_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jdermsci.2014.12.001","volume":"77","author":"R Smithrithee","year":"2015","unstructured":"Smithrithee R, Niyonsaba F, Kiatsurayanon C, et al. Human \u03b2-defensin-3 increases the expression of interleukin-37 through CCR6 in human keratinocytes. J Dermatol Sci. 2015;77(1):46\u201353.","journal-title":"J Dermatol Sci"},{"issue":"10","key":"11791_CR38","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nri1937","volume":"6","author":"H Tilg","year":"2006","unstructured":"Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6(10):772\u201383.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"11791_CR39","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1038\/oby.2008.394","volume":"16","author":"CC Wee","year":"2008","unstructured":"Wee CC, Huang A, Huskey KW, McCarthy EP. Obesity and the likelihood of sexual behavioral risk factors for HPV and cervical cancer. Obes (Silver Spring). 2008;16(11):2552\u20135.","journal-title":"Obes (Silver Spring)"},{"issue":"4","key":"11791_CR40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/cid\/ciy146","volume":"67","author":"M Gelpi","year":"2018","unstructured":"Gelpi M, Afzal S, Lundgren J, et al. Higher risk of abdominal obesity, elevated low-density lipoprotein cholesterol, and hypertriglyceridemia, but not of hypertension, in people living with human immunodeficiency virus (HIV): results from the Copenhagen comorbidity in HIV infection study. Clin Infect Dis. 2018;67(4):579\u201386.","journal-title":"Clin Infect Dis"},{"key":"11791_CR41","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ijid.2021.05.071","volume":"108","author":"M Kinoshita","year":"2021","unstructured":"Kinoshita M, Sato K, Vellingiri B, Green SJ, Tanaka M. Inverse association between hypertension treatment and COVID-19 prevalence in Japan. Int J Infect Dis. 2021;108:517\u201321.","journal-title":"Int J Infect Dis"},{"issue":"1\u20132","key":"11791_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11010-008-9905-3","volume":"321","author":"A Palaniyappan","year":"2009","unstructured":"Palaniyappan A, Uwiera RR, Idikio H, Jugdutt BI. Comparison of vasopeptidase inhibitor Omapatrilat and angiotensin receptor blocker Candesartan on extracellular matrix, myeloperoxidase, cytokines, and ventricular remodeling during healing after reperfused myocardial infarction. Mol Cell Biochem. 2009;321(1\u20132):9\u201322.","journal-title":"Mol Cell Biochem"},{"issue":"10204","key":"11791_CR43","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2019;394(10204):1145\u201358.","journal-title":"Lancet"},{"issue":"10","key":"11791_CR44","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"Global","year":"2021","unstructured":"Global. regional, and National burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. 2021;20(10):795\u2013820.","journal-title":"Lancet Neurol"},{"issue":"9","key":"11791_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222607","volume":"14","author":"J Dworza\u0144ski","year":"2019","unstructured":"Dworza\u0144ski J, Drop B, Kliszczewska E, Strycharz-Dudziak M, Polz-Dacewicz M. Prevalence of Epstein-Barr virus, human papillomavirus, cytomegalovirus and herpes simplex virus type 1 in patients with diabetes mellitus type 2 in south-eastern Poland. PLoS ONE. 2019;14(9):e0222607.","journal-title":"PLoS ONE"},{"issue":"4","key":"11791_CR46","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2174\/1566524020999200831124534","volume":"21","author":"F de Lourdes Ochoa-Gonz\u00e1lez","year":"2021","unstructured":"de Lourdes Ochoa-Gonz\u00e1lez F, Gonz\u00e1lez-Curiel IE, Cervantes-Villagrana AR, Fern\u00e1ndez-Ruiz JC, Casta\u00f1eda-Delgado JE. Innate immunity alterations in type 2 diabetes mellitus: Understanding infection susceptibility. Curr Mol Med. 2021;21(4):318\u201331.","journal-title":"Curr Mol Med"},{"issue":"Suppl 1Suppl1","key":"11791_CR47","first-page":"S27","volume":"16","author":"J Casqueiro","year":"2012","unstructured":"Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16(Suppl 1Suppl1):S27-36.","journal-title":"Indian J Endocrinol Metab"},{"issue":"9","key":"11791_CR48","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/ijc.33365","volume":"148","author":"K Reinholdt","year":"2021","unstructured":"Reinholdt K, Thomsen LT, Munk C, et al. Incidence of human papillomavirus-related anogenital precancer and cancer in women with diabetes: a nationwide registry-based cohort study. Int J Cancer. 2021;148(9):2090\u2013101.","journal-title":"Int J Cancer"},{"issue":"7","key":"11791_CR49","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1258\/ijsa.2010.010061","volume":"21","author":"M Yong","year":"2010","unstructured":"Yong M, Parkinson K, Goenka N, O\u2019Mahony C. Diabetes and genital warts: an unhappy coalition. Int J STD AIDS. 2010;21(7):457\u20139.","journal-title":"Int J STD AIDS"},{"issue":"2","key":"11791_CR50","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/jmv.27453","volume":"94","author":"J Niu","year":"2022","unstructured":"Niu J, Pan S, Wei Y, et al. Epidemiology and analysis of potential risk factors of high-risk human papillomavirus (HPV) in Shanghai China: a cross-sectional one-year study in non-vaccinated women. J Med Virol. 2022;94(2):761\u201370.","journal-title":"J Med Virol"},{"key":"11791_CR51","doi-asserted-by":"crossref","unstructured":"Abu-Farha M, Thanaraj TA, Qaddoumi MG, Hashem A, Abubaker J, Al-Mulla F. The role of lipid metabolism in COVID-19 virus infection and as a drug target. Int J Mol Sci. 2020;21(10):3544.","DOI":"10.3390\/ijms21103544"},{"issue":"3","key":"11791_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000329","volume":"5","author":"Q Xiong","year":"2009","unstructured":"Xiong Q, Lin M, Rikihisa Y. Cholesterol-dependent Anaplasma phagocytophilum exploits the low-density lipoprotein uptake pathway. PLoS Pathog. 2009;5(3):e1000329.","journal-title":"PLoS Pathog"},{"issue":"3","key":"11791_CR53","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ygyno.2012.08.033","volume":"127","author":"E Roset Bahmanyar","year":"2012","unstructured":"Roset Bahmanyar E, Paavonen J, Naud P, et al. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial. Gynecol Oncol. 2012;127(3):440\u201350.","journal-title":"Gynecol Oncol"},{"issue":"11","key":"11791_CR54","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1099\/jmm.0.000848","volume":"67","author":"H Bah Camara","year":"2018","unstructured":"Bah Camara H, Anyanwu M, Wright E, Kimmitt PT. Human papilloma virus genotype distribution and risk factor analysis amongst reproductive-age women in urban Gambia. J Med Microbiol. 2018;67(11):1645\u201354.","journal-title":"J Med Microbiol"},{"issue":"51","key":"11791_CR55","doi-asserted-by":"publisher","first-page":"110489","DOI":"10.1007\/s11356-023-30175-7","volume":"30","author":"L Jiang","year":"2023","unstructured":"Jiang L, Ma S, Zhang G, Jiang L, Yan L. Analysis of tobacco exposures and high-risk HPV infection in American women: national health and nutrition examination survey. Environ Sci Pollut Res Int. 2023;30(51):110489\u201398.","journal-title":"Environ Sci Pollut Res Int"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11791-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11791-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11791-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:04:30Z","timestamp":1763413470000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11791-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11791"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11791-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Peking University Institution Review Board on July 14, 2020 (IRB00001052\u201319077). Due to the retrospective design of the study, the requirement for informed consent was waived by the Peking University Institution Review Board. In addition, all methods were carried out in accordance with relevant guidelines and regulations or Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1599"}}